Recent developments in triple-helix regulation of gene expression

Anti-Cancer Drug Design

Volumn 12, Issue 5, 1997, Pages 433-442

  Neidle, Stephen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; OLIGODEOXYNUCLEOTIDE; PSORALEN;

DNA CONFORMATION; DNA CROSS LINKING; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG STABILITY; GENE REPRESSION; GENE TARGETING; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TRIPLE HELIX;

DNA; GENE EXPRESSION REGULATION; HUMANS; NUCLEIC ACID CONFORMATION;

EID: 0030861344     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. AGGARWAL, B.B., SCHWARZ, L., HOGAN, M.E. & RANDO, R.F. (1996). Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Research, 56, 5156.
2. ALUNNI-FABBRONI, M, PIRULLI, D., MANZINI, G. & XODO, L.E. (1996). (A,G)-Oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells. Biochemistry, 35, 16361.
3. BATES, PJ., LAUGHTON, C.A , JENKINS, T.C., CAPALDI, D.C., ROSELT, P.D., REESE, C.B. & NEIDLE, S. (1996). Efficient triple helix formation by oligodeoxyribonucleotides containing α- or β-2-amino-5-(2-deoxy-D-ribofuranosyl) pyridine residues. Nucleic Acids Research, 24, 4176.
4. 7-deoxyguanosine. Nucleic Acids Research, 24, 1987.
5. BUCHER, P. & YAGIL, G (1991). Occurrence of oligopurine-oligopyrimidine tracts in eukaryotic and prokaryotic genes. DNA Sequence, 1, 157.
6. CLARENC, J.P., LEBLEU, B. & LÉONETTI, J.P. (1993). Characterisation of the nuclear binding sites of oligodeoxyribonucleotides and their analogs. Journal of Biological Chemistry, 268, 5600.
7. COONEY, M., CZERNUSZEWICZ, G., POSTEL, E.H., FLINT, S.J. & HOGAN, M.E. (1988). Site-specific' oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science, 241, 456.
8. ESCUDÉ, C , SUN, J-S, NGUYEN, C H., BISAGNI, E.GARESTIER, T. & HÉLÈNE, C. (1996). Ligand-induced formation of triple helices with antiparallel third strands containing G and T. Biochemistry, 35, 5735.
9. FELSENFELD, G , DAVIES, D.R. & RICH, A. (1957). Formation of a three-stranded polynucleotide molecule. Journal of the American Chemical Society, 79, 2023.
10. FOX, K.R , POLUCCI, P, JENKINS, T.C & NEIDLE, S. (1995). A molecular anchor for stabilizing triple-helical DNA. Proceedings of the National Academy of Sciences of the USA, 92, 7887.
11. GIOVANNANGELI, C., DIVIACCO, S., LABROUSSE, V., GRYAZNOV, S., CHARNEAU, P. & HÉLÈNE, C. (1997). Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proceedings of the National Academy of Sciences, USA, 94, 79.
12. GRIGORIEV, M., PRASEUTH, D., ROBIN, P., HEMAR, A , SAISON-BEHMOARAS, T., DAUTRY-VARSAT, A , THOUNG, N T., HÉLENE, C. & HAREL-BELLAN, A. (1992). A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF κB binding to interleukin-2 receptor α-regulatory sequence. Journal of Biological Chemistry, 267, 3389.
13. GUIEYSSE, A-L., PRASEUTH, D., GRIGORIEV, M., HAREL-GELLAN, A. & HÉLÈNE, C. (1996). Detection of covalent triplex within human cells. Nucleic Acids Research, 24, 4210.
14. GUNTHER, E.J., HAVRE, P.A., GASPARRO, F.P. & GLAZER, PM. (1996). Triplex-mediated, in vitro targeting of psoralen photoadducts within the genome of a transgenic mouse. Photochemistry and Photobiology, 63, 207.
15. HARDENBOL, P & VAN DYKE, M.W. (1996). Sequence specificity of triplex DNA formation: analysis by a combinatorial approach, restriction endonuclease protection selection and amplification. Proceedings of the National Academy of Sciences, USA, 93, 2811.
16. HÉLÈNE, C. (1991). The antigene strategy: control of gene expression by triple helix-forming oligonucleotides. Anti-Cancer Drug Design, 6, 569.
17. HILDBRAND, S, & LEUMANN, C (1996). Enhanced DNA triple helix stability at neutral pH by the use of oligonucleotides containing a more basic deoxycytidine analog. Angewante Chemie, International Edition, 35, 1968.
18. ING, N.H., BEEKMAN, J.M., KESSLER, D.J., MURPHY, M., JAYARAMAN, K., ZENDEGUI, J.G , HOGAN, M.E., O'MALLEY, B.W. &TSAI, M.J. (1993). In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. Nucleic Acids Research, 21, 2789.
19. KOCHETKOVA, M. & SHANNON M F. (1996). DNA triplex formation selectivity inhibits granulocyte-macrophage colony-stimulating factor gene expression in human T cells. Journal of Biological Chemistry, 271, 14438.
20. LAVROVSKY, Y., STOLTZ, R.A., VLASSOV, V.V. & ABRAHAM, N.G. (1996). c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro. European Journal of Biochemistry, 238, 582.
21. +-containing DNA triplexes. Biochemistry, 32, 5591.
22. MACAULAY, VM., BATES, P.J., McLEAN, M.J., ROWLANDS, M G., JENKINS, T.C., ASHWORTH, A. & NEIDLE, S. (1995). Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence. FEBS Letters, 372, 222.
23. MAHER, L.J. III (1996). Prospects for the therapeutic use of antigene oligonucleotides. Cancer Investigation, 14, 66.
24. MERGNY, J L, DUVAL-VALENTIN, G, NGUYEN, C.H., PERROUALT, L., FAUCON, B., ROUGÉE, M., MONTENAY-GARESTIER, T., BISAGNI, E. & HÉLÈNE, C. (1992). Triple-helix specific ligands. Science, 256, 1681.
25. MOSER, H. & DERVAN, P.B. (1987). Sequence-specific cleavage of double-helical DNA by triple-helix formation. Science, 238, 645.
26. MUSSO, J., WANG, C.J. & VAN DYKE, M.W. (1996). In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides. Nucleic Acids Research, 24, 4924.
27. NIELSEN, PE (1995). DNA analogues with non-phosphodiester backbones. Annual Reviews of Biophysics and Biomolecular Structure, 24, 167.
28. OLIVAS, WM, & MAHER, L J III (1996). Binding of DNA oligonucleotides to sequences in the promoter of the human bcl-2 gene. Nucleic Acids Research, 24, 1758.
29. PORUMB, H., GOUSSET, H., LETELLIER. R., SALLE, V, BRIANE, D, VASSY, J, AMOR-GUERET, M, ISRAĒL & TAILLANDIER. E. (1996). Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide. Cancer Research, 56, 515.
30. RADHAKRISHNAN, I & PATEL, D J (1994). DNA triplexes: solution structures, hydration sites, energetics, interactions and function. Biochemistry, 33, 11405.
31. RAHA, M., WANG, G, SEIDMAN, M.M & GLAZER, PM (1996). Mutagenesis by third-strand-directed psoralen adducts in repair-deficient human cells: high frequency and altered spectrum in a xeroderma pigmentosum variant. Proceedings of the National Academy of Sciences, USA, 93, 2941.
32. RANDO, R.F., DE PAOLIS, L , DURLAND, R.H , JAYARAMAN, K , KESSLER, D.J. & HOGAN, M E. (1994). Inhibition of T7 and T3 polymerase directed transcription elongation in vitro. Nucleic Acids Research, 22, 678.
33. SANDOR, z. & BREDBERG, A. (1995). Deficient DNA repair of triple helix-directed double psoralen damage in human cells. FEBS Letters, 374, 287.
34. SILVER, G.C., SUN, J.-S., NGUYEN, C.H., BOUTORINE, A.S., BISAGNI, E, & HÉLÈNE, C. (1997). Stable triple-helical DNA complexes formed by benzopyridoindole- and benzopyridoquinoxaline-oligonucleotide conjugates. Journal of the American Chemical Society, 119, 263.
35. SOFYER, V.N. & POTAMAN, V.N. (1996). Triple-Helical Nucleic Acids. Springer: New York.
36. STREKOWSKI, L., GULEVICH, Y., BARANOWSKI, T.C., PARKER, A.N , KISELYOV, A S , LIN, S.-Y., TANIOUS, F.A. & WILSON, w.D. (1996). Synthesis and structure-DNA binding relationship analysis of DNA triple-helix specific intercalators. Journal of Medicinal Chemistry; 39, 3980.
37. SUN, J.-S., GARESTIER, T. & HéLèNE, C. (1996). Oligonucleotide directed triple helix formation. Current Opinion in Structural Biology, 6, 327.
38. SVINARCHUK, F, DEBIN, A , BERTRAND, J-R. & MALVY, C. (1996). Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promoter. Nucleic Acids Research, 24, 295.
39. THOMAS, T.J., FAALAND, C.A., GALLO, M.A. & THOMAS, T. (1995). Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells. Nucleic Acids Research, 23, 3594.
40. THOUNG, N.T. & HÉLÈNE, C (1993). Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angewante Chemie, International Edition, 32, 666.
41. TU, G-C , CAO, Q-N & ISRAEL, Y. (1995). Inhibition of gene expression by triple helix formation in hepatoma cells. Journal of Biological Chemistry, 270, 28402.
42. WANG, G. & GLAZER, P.M. (1995). Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix. Journal of Biological Chemistry, 270, 22595.
43. WANG, G. SEIDMAN, M.M & GLAZER P.M. (1996). Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science, 271, 802.
44. XIANG, G., BOGACKI, R. & MCLAUGHLIN, L.W. (1996). Use of a pyrimidine nucleoside that functions as a bidentate hydrogen bond donor for the recognition of isolated or contiguous G-C base pairs by oligonucleotide-directed triplex formation. Nucleic Acids Research, 24, 1963.
45. ZHOU, B W, MARCHAND, C., ASSELINE, U., THUONG, N.T., SUN, J.S., GARESTIER, T. & HÉLÈNE, C. (1995). Stable triple helices formed by acridine-containing oligonucleotides with oligopurine tracts of DNA interrupted by one or two pyrimidines. Journal of the American Chemical Society, 117, 10425.
46. ZIMMERMAN, S.C. & SCHMITT, P. (1995). Model studies toward a general triplex DNA recognition scheme: a novel DNA base that binds a CG base pair in an organic solvent. Journal of the American Chemical Society, 117, 10769.